Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TT6R7JZ)

• DTT Name: Histone deacetylase 1 (HDAC1) DTT Info
• Gene Name: HDAC1

Molecule-Related Drug & Molecule List

4 Approved Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Panobinostat	DM58WKG	Chronic graft versus host disease		Approved	[1]
Romidepsin	DMT5GNL	Cutaneous T-cell lymphoma	2B01	Approved	[2]
Vorinostat	DMWMPD4	Adult acute monocytic leukemia		Approved	[1]
HBI-8000	DMDWYUN	Non-small-cell lung cancer	2C25.Y	Registered	[3]

12 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
ITF2357	DMFZBNE	Duchenne dystrophy	8C70	Phase 3	[4]
NVP-LAQ824	DM8JWNA	Mood disorder	6A60-6E23	Phase 3	[5]
SNDX-275	DMH7W9X	Breast cancer	2C60-2C65	Phase 3	[6]
MGCD-0103	DM726HX	Non-small-cell lung cancer	2C25.Y	Phase 2	[1]
Phenylbutyrate	DMBHPDW	Urea cycle disorder	5C50.A	Phase 2	[7]
Resminostat	DMNE1FR	Hepatocellular carcinoma	2C12.02	Phase 2	[8]
SB-623	DM4NY58	Cerebrovascular ischaemia	8B1Z	Phase 2	[9]
Sodium butyrate	DMKNIVG	Acute myeloid leukaemia	2A60	Phase 2	[10]
CHR-3996	DMIXPNG	Lymphoma	2A80-2A86	Phase 1/2	[11]
OBP-801	DMPLV9G	Solid tumour/cancer	2A00-2F9Z	Phase 1	[12]
RG-2833	DM7B650	Friedreich's ataxia	8A03.10	Phase 1	[3]
SB-639	DMSZIP5	Solid tumour/cancer	2A00-2F9Z	Phase 1	[9]

76 Patented Agent(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Diaryl amine derivative 2	DMRBYAV	N. A.	N. A.	Patented	[13]
Diaryl amine derivative 3	DMLBN1T	N. A.	N. A.	Patented	[13]
Isosteric imidazolyl pyrimidine derivative 1	DMP2QDM	N. A.	N. A.	Patented	[14]
PMID28092474-Compound-32a	DMGZ61E	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-32b	DMT2B5A	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-32c	DMGA3XL	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-32d	DMW21U4	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-32e	DM8NHQS	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-32f	DMEIZ6Y	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-32g	DMTKLEP	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-32h	DME1WHT	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-32i	DMN3ZEF	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-32j	DMSGWTX	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-32k	DMHSJ65	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-32l	DMSP5IA	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-32m	DMADMWB	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-32n	DMJO3RW	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-32o	DMV9BQN	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-32p	DM4ZO21	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-32q	DMEASZY	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-32r	DMLTKMS	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-32s	DMS103B	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-32t	DM2JF0T	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-32u	DM805ZN	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-32v	DMHV3ES	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-32x	DML79XQ	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-32y	DMLR03U	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-32z	DMEPWGH	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-33a	DM7GH4Y	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-33b	DMIJQZV	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-33c	DM51JP6	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-33d	DMW38MK	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-33e	DMGTSXL	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-33f	DMA360M	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-33g	DM18DY6	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-33h	DM1DN6V	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-33i	DM16E95	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-33j	DMNTRIZ	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-33k	DMF2ZNT	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-33l	DMPJSB2	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-33m	DMXSPT9	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-33o	DM6DJZ7	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-33p	DMI8ZBK	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-34a	DMXQE7C	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-34b	DM6X2CO	N. A.	N. A.	Patented	[13]
PMID28092474-Compound-34c	DMMI7DY	N. A.	N. A.	Patented	[13]
PMID29671355-Compound-11	DMNKABH	N. A.	N. A.	Patented	[15]
PMID29671355-Compound-13	DMALXYR	N. A.	N. A.	Patented	[15]
PMID29671355-Compound-18	DMUY53P	N. A.	N. A.	Patented	[15]
PMID29671355-Compound-19	DM9LMNB	N. A.	N. A.	Patented	[15]
PMID29671355-Compound-21	DMPJN0M	N. A.	N. A.	Patented	[15]
PMID29671355-Compound-22	DMRGV83	N. A.	N. A.	Patented	[15]
PMID29671355-Compound-23	DMUBOEX	N. A.	N. A.	Patented	[15]
PMID29671355-Compound-24	DMCIGJ1	N. A.	N. A.	Patented	[15]
PMID29671355-Compound-25	DMPV0KZ	N. A.	N. A.	Patented	[15]
PMID29671355-Compound-26	DM5K6MG	N. A.	N. A.	Patented	[15]
PMID29671355-Compound-27	DMP7S9E	N. A.	N. A.	Patented	[15]
PMID29671355-Compound-28	DMLXSHW	N. A.	N. A.	Patented	[15]
PMID29671355-Compound-31	DM3H78D	N. A.	N. A.	Patented	[15]
PMID29671355-Compound-38a	DMYATB5	N. A.	N. A.	Patented	[15]
PMID29671355-Compound-38b	DMYXE4J	N. A.	N. A.	Patented	[15]
PMID29671355-Compound-39	DM6EJ93	N. A.	N. A.	Patented	[15]
PMID29671355-Compound-42	DMXY103	N. A.	N. A.	Patented	[15]
PMID29671355-Compound-43	DMVPMWJ	N. A.	N. A.	Patented	[15]
PMID29671355-Compound-44	DM80A3V	N. A.	N. A.	Patented	[15]
PMID29671355-Compound-55	DMJV1SY	N. A.	N. A.	Patented	[15]
PMID29671355-Compound-56	DM0VBMI	N. A.	N. A.	Patented	[15]
PMID29671355-Compound-57	DM57N3Y	N. A.	N. A.	Patented	[15]
PMID29671355-Compound-59	DM2F0CQ	N. A.	N. A.	Patented	[15]
PMID29671355-Compound-61	DMXH1G3	N. A.	N. A.	Patented	[15]
PMID29671355-Compound-62	DMWRS34	N. A.	N. A.	Patented	[15]
PMID29671355-Compound-65a	DMY3Q58	N. A.	N. A.	Patented	[15]
PMID29671355-Compound-67	DM1RPL4	N. A.	N. A.	Patented	[15]
PMID29671355-Compound-73	DMCNF36	N. A.	N. A.	Patented	[15]
PMID29671355-Compound-8	DM7YQJK	N. A.	N. A.	Patented	[15]
PMID29671355-Compound-9	DMXL96M	N. A.	N. A.	Patented	[15]

4 Discontinued Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
AN-9	DMGL0Q2	Melanoma	2C30	Discontinued in Phase 2	[10]
Tacedinaline	DM1Z74X	Solid tumour/cancer	2A00-2F9Z	Discontinued in Phase 2	[9]
Pyroxamide	DM4LNBQ	Solid tumour/cancer	2A00-2F9Z	Discontinued in Phase 1	[9]
Oxamflatin	DM1TG3C	Solid tumour/cancer	2A00-2F9Z	Terminated	[9]

8 Preclinical Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
4SC-202	DMXFC3W	Solid tumour/cancer	2A00-2F9Z	Preclinical	[8]
Chlamydocin	DM89DQP	Solid tumour/cancer	2A00-2F9Z	Preclinical	[9]
Depudecin	DMD0T1U	Solid tumour/cancer	2A00-2F9Z	Preclinical	[9]
HC-Toxin	DMPLZ7E	Solid tumour/cancer	2A00-2F9Z	Preclinical	[9]
M-carboxycinnamic acid bishydroxamide	DMHJLPS	Solid tumour/cancer	2A00-2F9Z	Preclinical	[9]
Scriptaid	DM9JZ21	Solid tumour/cancer	2A00-2F9Z	Preclinical	[9]
SK-7041	DM7DNOG	Solid tumour/cancer	2A00-2F9Z	Preclinical	[9]
SK-7068	DMCI371	Solid tumour/cancer	2A00-2F9Z	Preclinical	[9]

146 Investigative Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
(E)-8-Biphenyl-4-yl-1-oxazol-2-yl-oct-7-en-1-one	DM5LSY9	Discovery agent	N.A.	Investigative	[16]
1,1,1-Trifluoro-8-(4-phenoxy-phenoxy)-octan-2-one	DM6GI4Z	Discovery agent	N.A.	Investigative	[17]
1,1,1-Trifluoro-8-phenoxy-octan-2-one	DM41R2O	Discovery agent	N.A.	Investigative	[17]
2-(methylsulfonylthio)ethyl 2-propylpentanoate	DMM52D3	Discovery agent	N.A.	Investigative	[18]
4-Benzenesulfonylamino-N-hydroxy-benzamide	DMM6UPD	Discovery agent	N.A.	Investigative	[19]
4-Benzoylamino-N-hydroxy-benzamide	DMYBPFS	Discovery agent	N.A.	Investigative	[20]
4-Butyrylamino-N-hydroxy-benzamide	DMRY6B4	Discovery agent	N.A.	Investigative	[21]
4-Chloro-N-(5-hydroxycarbamoyl-pentyl)-benzamide	DM5AVG3	Discovery agent	N.A.	Investigative	[22]
4-Dimethylamino-N-(6-mercapto-hexyl)-benzamide	DM0M8G5	Discovery agent	N.A.	Investigative	[23]
4-Hydroxy-N-(5-hydroxycarbamoyl-pentyl)-benzamide	DMULOHZ	Discovery agent	N.A.	Investigative	[24]
4-Phenylbutyrohydroxamic acid	DMCZKN7	Discovery agent	N.A.	Investigative	[25]
4-tert-butyl-N-hydroxybenzamide	DMUWTPX	Discovery agent	N.A.	Investigative	[26]
5-(4-Chloro-phenyl)-pentanoic acid hydroxyamide	DM6CRVS	Discovery agent	N.A.	Investigative	[27]
5-(4-hydroxyphenyl)-3H-1,2-dithiole-3-thione	DM7KQXL	Discovery agent	N.A.	Investigative	[18]
5-Mercapto-pentanoic acid phenylamide	DMET3OJ	Discovery agent	N.A.	Investigative	[23]
6-(2-Bromo-acetylamino)-hexanoic acid phenylamide	DM9LKXD	Discovery agent	N.A.	Investigative	[23]
6-(3-Benzoyl-ureido)-hexanoic acid hydroxyamide	DMQZTS3	Discovery agent	N.A.	Investigative	[28]
6-(9H-carbazol-9-yl)-N-hydroxyhexanamide	DMVMDJ3	Discovery agent	N.A.	Investigative	[29]
6-benzenesulfinylhexanoic acid hydroxamide	DM2I95Z	Discovery agent	N.A.	Investigative	[30]
6-benzenesulfonylhexanoic acid hydroxamide	DMY9IK8	Discovery agent	N.A.	Investigative	[30]
6-Mercapto-hexanoic acid phenylamide	DMD2FW9	Discovery agent	N.A.	Investigative	[23]
6-Phenoxy-hexane-1-thiol	DMVYIN2	Discovery agent	N.A.	Investigative	[23]
6-phenylsulfanylhexanoic acid hydroxamide	DM3OLM6	Discovery agent	N.A.	Investigative	[30]
7-(1H-indol-5-yloxy)-N-hydroxyheptanamide	DMOZV9W	Discovery agent	N.A.	Investigative	[31]
7-(3-Benzoyl-ureido)-heptanoic acid hydroxyamide	DMCFV0X	Discovery agent	N.A.	Investigative	[28]
7-(4-(dimethylamino)phenoxy)-N-hydroxyheptanamide	DM2TNCK	Discovery agent	N.A.	Investigative	[31]
7-(Biphenyl-3-yloxy)-1-oxazol-2-yl-heptan-1-one	DMLCGSY	Discovery agent	N.A.	Investigative	[16]
7-(Biphenyl-4-yloxy)-1,1,1-trifluoro-heptan-2-one	DM28GZ7	Discovery agent	N.A.	Investigative	[17]
7-(Biphenyl-4-yloxy)-1-oxazol-2-yl-heptan-1-one	DMY027P	Discovery agent	N.A.	Investigative	[16]
7-(Biphenyl-4-yloxy)-heptanoic acid hydroxyamide	DMO4YLA	Discovery agent	N.A.	Investigative	[32]
7-(Naphthalen-2-yloxy)-1-oxazol-2-yl-heptan-1-one	DM4VQN8	Discovery agent	N.A.	Investigative	[16]
7-Biphenyl-4-yl-heptanoic acid hydroxyamide	DMV54MT	Discovery agent	N.A.	Investigative	[33]
7-Mercapto-heptanoic acid benzothiazol-2-ylamide	DMPYTHV	Discovery agent	N.A.	Investigative	[23]
7-Mercapto-heptanoic acid biphenyl-3-ylamide	DMEQKPO	Discovery agent	N.A.	Investigative	[23]
7-Mercapto-heptanoic acid biphenyl-4-ylamide	DMJMOUK	Discovery agent	N.A.	Investigative	[23]
7-Mercapto-heptanoic acid phenylamide	DM4912P	Discovery agent	N.A.	Investigative	[23]
7-Mercapto-heptanoic acid pyridin-3-ylamide	DMQ9PLA	Discovery agent	N.A.	Investigative	[23]
7-Mercapto-heptanoic acid quinolin-3-ylamide	DMTAGJ1	Discovery agent	N.A.	Investigative	[23]
7-mercapto-N-(4-phenylthiazol-2-yl)heptanamide	DM03XYF	Discovery agent	N.A.	Investigative	[34]
7-Phenoxy-heptanoic acid hydroxyamide	DM1FL5G	Discovery agent	N.A.	Investigative	[33]
8-(3-Benzoyl-ureido)-octanoic acid hydroxyamide	DMW2NJR	Discovery agent	N.A.	Investigative	[28]
8-(4-bromophenyl)-N-hydroxy-8-oxooctanamide	DMVOCWY	Discovery agent	N.A.	Investigative	[35]
8-(Biphenyl-3-yloxy)-1,1,1-trifluoro-octan-2-one	DMH3SDO	Discovery agent	N.A.	Investigative	[17]
8-(biphenyl-4-yl)-N-hydroxy-8-oxooctanamide	DMD6VSY	Discovery agent	N.A.	Investigative	[35]
8-(Biphenyl-4-yloxy)-1,1,1-trifluoro-octan-2-one	DM23XGW	Discovery agent	N.A.	Investigative	[17]
8-(Biphenyl-4-yloxy)-2-oxo-octanoic acid	DMDIGPW	Discovery agent	N.A.	Investigative	[32]
8-Mercapto-octanoic acid phenylamide	DMD3FWU	Discovery agent	N.A.	Investigative	[23]
8-Oxo-8-phenyl-octanoic acid	DMXDQ25	Discovery agent	N.A.	Investigative	[24]
8-Oxo-8-phenyl-octanoic acid hydroxyamide	DMWM1UL	Discovery agent	N.A.	Investigative	[22]
8-Phenyl-octanoic acid hydroxyamide	DM516NE	Discovery agent	N.A.	Investigative	[33]
9,9,9-Trifluoro-8-oxo-nonanoic acid phenylamide	DMVBCID	Discovery agent	N.A.	Investigative	[17]
9-(Biphenyl-4-yloxy)-1,1,1-trifluoro-nonan-2-one	DMIY3D6	Discovery agent	N.A.	Investigative	[17]
ADS-100380	DM7U4OT	Discovery agent	N.A.	Investigative	[36]
ADS-102550	DMEU6MH	Discovery agent	N.A.	Investigative	[36]
Azithromycin-N-benzyltriazolyldecahydroxamic Acid	DMDQ2VN	Discovery agent	N.A.	Investigative	[37]
Azithromycin-N-benzyltriazolylhexahydroxamic Acid	DM7KD5Y	Discovery agent	N.A.	Investigative	[37]
Azithromycin-N-benzyltriazolylnonahydroxamic Acid	DMW0HXO	Discovery agent	N.A.	Investigative	[37]
Azithromycin-N-benzyltriazolyloctahydroxamic Acid	DMAJ4LI	Discovery agent	N.A.	Investigative	[37]
Azithromycinarylalkylhydroxamic Acid	DM8ZQG3	Discovery agent	N.A.	Investigative	[37]
AZUMAMIDE B	DMXOGE8	Discovery agent	N.A.	Investigative	[38]
AZUMAMIDE C	DMEBA61	Discovery agent	N.A.	Investigative	[38]
AZUMAMIDE E	DMAX06G	Discovery agent	N.A.	Investigative	[38]
Cyclo(-L-Am7(S2Py)-A2in-L-Ala-D-Pro-)	DMZF35W	Discovery agent	N.A.	Investigative	[39]
Cyclo(-L-Am7(S2Py)-Aib-L-Ala-D-Pro-)	DMIVREK	Discovery agent	N.A.	Investigative	[39]
Cyclo(-L-Am7(S2Py)-Aib-L-Ala-D-Tic-)	DMLBECR	Discovery agent	N.A.	Investigative	[39]
Cyclo(-L-Am7(S2Py)-Aib-L-Ph4-D-Pro-)	DMA76KW	Discovery agent	N.A.	Investigative	[39]
Cyclo(-L-Am7(S2Py)-Aib-L-Ph5-D-Pro-)	DMLNJ0O	Discovery agent	N.A.	Investigative	[39]
Cyclo(-L-Am7(S2Py)-Aib-L-Phe-D-Pro-)	DMTVMWA	Discovery agent	N.A.	Investigative	[39]
Cyclo(-L-Am7(S2Py)-Aib-L-Phg-D-Pro-)	DMUSEDF	Discovery agent	N.A.	Investigative	[39]
Cyclo(-L-Am7(S2Py)-Aib-L-Ser(Bzl)-D-Pro-)	DMSEQ0W	Discovery agent	N.A.	Investigative	[39]
Cyclo(-L-Am7(S2Py)-Aib-L-Ser-D-Pro-)	DMBKP48	Discovery agent	N.A.	Investigative	[39]
Cyclo(-L-Am7(S2Py)-D-2MePhe-L-Ala-D-Pro-)	DMVY89X	Discovery agent	N.A.	Investigative	[39]
Cyclo(-L-Am7(S2Py)-D-A1in-L-Ala-D-Pro-)	DMTDIM9	Discovery agent	N.A.	Investigative	[39]
Cyclo(-L-Am7(S2Py)-L-2MePhe-L-Ala-D-Pro-)	DMV23XD	Discovery agent	N.A.	Investigative	[39]
Cyclo(-L-Am7(S2Py)-L-A1in-L-Ala-D-Pro-)	DM0VIH4	Discovery agent	N.A.	Investigative	[39]
Cyclostellettamine derivative	DMFTDPQ	Discovery agent	N.A.	Investigative	[40]
Desclasinose Azithromycinarylalkyl Hydroxamate	DMAB9KG	Discovery agent	N.A.	Investigative	[37]
Gymnochrome E	DM7SLAM	Discovery agent	N.A.	Investigative	[41]
LARGAZOLE	DMSYLIJ	Discovery agent	N.A.	Investigative	[42]
N,8-dihydroxy-8-(naphthalen-2-yl)octanamide	DM8G0WX	Discovery agent	N.A.	Investigative	[35]
N-(2,3-Dimethylphenyl)-N'-hydroxyoctanediamide	DM5R3ZG	Discovery agent	N.A.	Investigative	[43]
N-(2,4-Dimethylphenyl)-N'-hydroxyoctanediamide	DMXA9MR	Discovery agent	N.A.	Investigative	[43]
N-(2,5-Dimethylphenyl)-N'-hydroxyoctanediamide	DMOL79W	Discovery agent	N.A.	Investigative	[43]
N-(2,6-Dimethylphenyl)-N'-hydroxyoctanediamide	DMTBAPH	Discovery agent	N.A.	Investigative	[43]
N-(2-amino-5-(thiophen-2-yl)phenyl)nicotinamide	DMFYG79	Discovery agent	N.A.	Investigative	[44]
N-(2-aminophenyl)-4-(chroman-3-ylmethyl)benzamide	DMT7JUC	Discovery agent	N.A.	Investigative	[45]
N-(2-aminophenyl)-4-methoxybenzamide	DMTKWUM	Discovery agent	N.A.	Investigative	[46]
N-(2-aminophenyl)nicotinamide	DMRDQ1B	Discovery agent	N.A.	Investigative	[44]
N-(2-aminophenyl)quinoxaline-6-carboxamide	DMJXV7C	Discovery agent	N.A.	Investigative	[46]
N-(2-Ethylphenyl)-N'-hydroxyoctanediamide	DMDM50P	Discovery agent	N.A.	Investigative	[43]
N-(2-Mercapto-ethyl)-N'-phenyl-oxalamide	DM0GOPV	Discovery agent	N.A.	Investigative	[47]
N-(2-Mercapto-ethyl)-N'-phenyl-succinamide	DMJLFOQ	Discovery agent	N.A.	Investigative	[47]
N-(3,4-Dimethylphenyl)-N'-hydroxyoctanediamide	DMEP2VM	Discovery agent	N.A.	Investigative	[43]
N-(3,5-Dimethylphenyl)-N'-hydroxyoctanediamide	DM1L3FM	Discovery agent	N.A.	Investigative	[43]
N-(3-Ethylphenyl)-N'-hydroxyoctanediamide	DMC5G6Y	Discovery agent	N.A.	Investigative	[43]
N-(4-aminobiphenyl-3-yl)nicotinamide	DMXVZIY	Discovery agent	N.A.	Investigative	[44]
N-(4-Ethylphenyl)-N'-hydroxyoctanediamide	DMKN8U6	Discovery agent	N.A.	Investigative	[43]
N-(4-hydroxybiphenyl-3-yl)benzamide	DMC5H8G	Discovery agent	N.A.	Investigative	[44]
N-(5-Hydroxycarbamoyl-pentyl)-4-nitro-benzamide	DMSUW7M	Discovery agent	N.A.	Investigative	[22]
N-(6-Hydroxycarbamoyl-hexyl)-benzamide	DMIZVMT	Discovery agent	N.A.	Investigative	[24]
N-(6-Mercapto-hexyl)-benzamide	DM01Y37	Discovery agent	N.A.	Investigative	[23]
N-hydroxy-2,2'-bithiophene-5-carboxamide	DMWIMR4	Discovery agent	N.A.	Investigative	[36]
N-Hydroxy-4-((R)-2-phenyl-butyrylamino)-benzamide	DMCN91A	Discovery agent	N.A.	Investigative	[20]
N-Hydroxy-4-((S)-2-phenyl-butyrylamino)-benzamide	DMVK2Y3	Discovery agent	N.A.	Investigative	[20]
N-Hydroxy-4-(2-phenyl-butyrylamino)-benzamide	DMHEQ41	Discovery agent	N.A.	Investigative	[20]
N-Hydroxy-4-(3-phenyl-propionylamino)-benzamide	DMUOCQB	Discovery agent	N.A.	Investigative	[48]
N-Hydroxy-4-(4-phenyl-butyrylamino)-benzamide	DMVEOBY	Discovery agent	N.A.	Investigative	[20]
N-Hydroxy-4-(5-phenyl-pentanoylamino)-benzamide	DMISRMT	Discovery agent	N.A.	Investigative	[20]
N-Hydroxy-4-(pentanoylamino-methyl)-benzamide	DMGTNQY	Discovery agent	N.A.	Investigative	[21]
N-Hydroxy-4-(phenylacetylamino-methyl)-benzamide	DMDUOH4	Discovery agent	N.A.	Investigative	[21]
N-Hydroxy-4-phenylacetylamino-benzamide	DMCRU17	Discovery agent	N.A.	Investigative	[20]
N-hydroxy-5-(pyridin-2-yl)thiophene-2-carboxamide	DMYKJZ2	Discovery agent	N.A.	Investigative	[36]
N-hydroxy-5-(pyridin-3-yl)thiophene-2-carboxamide	DMK98LE	Discovery agent	N.A.	Investigative	[36]
N-hydroxy-5-(pyridin-4-yl)thiophene-2-carboxamide	DM653RM	Discovery agent	N.A.	Investigative	[36]
N-hydroxy-5-phenylthiophene-2-carboxamide	DMA2WUQ	Discovery agent	N.A.	Investigative	[36]
N-hydroxy-6-oxo-6-phenylhexanamide	DM0JNO2	Discovery agent	N.A.	Investigative	[35]
N-hydroxy-7-(4-methoxyphenyl)-7-oxoheptanamide	DMUXZL1	Discovery agent	N.A.	Investigative	[35]
N-hydroxy-7-(naphthalen-2-yl)-7-oxoheptanamide	DM8Z4L0	Discovery agent	N.A.	Investigative	[35]
N-hydroxy-7-(naphthalen-2-yloxy)heptanamide	DMBUNAP	Discovery agent	N.A.	Investigative	[31]
N-hydroxy-7-oxo-7-phenylheptanamide	DMQW7JZ	Discovery agent	N.A.	Investigative	[35]
N-hydroxy-8-(2-methoxyphenyl)-8-oxooctanamide	DMSIMNR	Discovery agent	N.A.	Investigative	[35]
N-hydroxy-8-(4-methoxyphenyl)-8-oxooctanamide	DMD2K4T	Discovery agent	N.A.	Investigative	[35]
N-hydroxy-8-(naphthalen-2-yl)non-8-enamide	DMRN1C6	Discovery agent	N.A.	Investigative	[35]
N-hydroxy-8-(naphthalen-2-yl)oct-7-enamide	DMGZY1Q	Discovery agent	N.A.	Investigative	[35]
N-hydroxy-8-(naphthalen-2-yl)octanamide	DMXQICK	Discovery agent	N.A.	Investigative	[35]
N-hydroxy-8-oxo-8-(pyridin-3-yl)octanamide	DMO4CR7	Discovery agent	N.A.	Investigative	[35]
N-hydroxy-9-oxo-9-phenylnonanamide	DMIC2A8	Discovery agent	N.A.	Investigative	[35]
N-Hydroxy-N'-(2-methylphenyl)octanediamide	DM865Y2	Discovery agent	N.A.	Investigative	[43]
N-Hydroxy-N'-(3-methylphenyl)octanediamide	DMYRC2M	Discovery agent	N.A.	Investigative	[43]
N-Hydroxy-N'-(4-methoxyphenyl)octanediamide	DMELB07	Discovery agent	N.A.	Investigative	[43]
N-Hydroxy-N'-(4-methylphenyl)octanediamide	DM3DPZ8	Discovery agent	N.A.	Investigative	[43]
N-hydroxybenzo[b]thiophene-2-carboxamide	DMR4J8G	Discovery agent	N.A.	Investigative	[49]
N1-(biphenyl-3-yl)-N8-hydroxyoctanediamide	DMMQXON	Discovery agent	N.A.	Investigative	[50]
N1-(biphenyl-4-yl)-N8-hydroxyoctanediamide	DMZA8NC	Discovery agent	N.A.	Investigative	[51]
N1-hydroxy-N8-(4-phenylthiazol-2-yl)octanediamide	DMOZARM	Discovery agent	N.A.	Investigative	[51]
nexturastat A	DM6NS7H	Discovery agent	N.A.	Investigative	[52]
NSC-746457	DM2GO7N	Discovery agent	N.A.	Investigative	[53]
Octanedioic acid bis-hydroxyamide	DMJNQ9K	Discovery agent	N.A.	Investigative	[54]
Octanedioic acid hydroxyamide pyridin-2-ylamide	DMHNWS1	Discovery agent	N.A.	Investigative	[24]
Octanedioic acid hydroxyamide pyridin-4-ylamide	DM945RK	Discovery agent	N.A.	Investigative	[24]
PSAMMAPLIN A	DM6T0IQ	Discovery agent	N.A.	Investigative	[22]
SK-683	DMM32CF	Discovery agent	N.A.	Investigative	[55]
ST-2986	DMNERM6	Discovery agent	N.A.	Investigative	[56]
ST-2987	DMWXTM8	Solid tumour/cancer	2A00-2F9Z	Investigative	[56]
ST-3050	DM19K2D	Discovery agent	N.A.	Investigative	[56]
Thioacetic acid S-(6-phenylcarbamoyl-hexyl) ester	DMBOKSF	Discovery agent	N.A.	Investigative	[23]

References

• [1] Protein methyltransferases as a target class for drug discovery. Nat Rev Drug Discov. 2009 Sep;8(9):724-32.
• [2] Hughes B: 2009 FDA drug approvals. Nat Rev Drug Discov. 2010 Feb;9(2):89-92.
• [3] Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.
• [4] Emerging drugs for the therapy of primary and post essential thrombocythemia, post polycythemia vera myelofibrosis. Expert Opin Emerg Drugs. 2009 Sep;14(3):471-9.
• [5] NVP-LAQ824 is a potent novel histone deacetylase inhibitor with significant activity against multiple myeloma. Blood. 2003 Oct 1;102(7):2615-22.
• [6] Emerging therapies for multiple myeloma. Expert Opin Emerg Drugs. 2009 Mar;14(1):99-127.
• [7] Emerging disease-modifying therapies for the treatment of motor neuron disease/amyotropic lateral sclerosis. Expert Opin Emerg Drugs. 2007 May;12(2):229-52.
• [8] 2011 Pipeline of 4SC AG.
• [9] Histone deacetylase inhibitors in cancer therapy: latest developments, trends and medicinal chemistry perspective. Anticancer Agents Med Chem. 2007 Sep;7(5):576-92.
• [10] Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov. 2006 Sep;5(9):769-84.
• [11] A phase I pharmacokinetic and pharmacodynamic study of CHR-3996, an oral class I selective histone deacetylase inhibitor in refractory solid tumors. Clin Cancer Res. 2012 May 1;18(9):2687-94.
• [12] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2658).
• [13] Novel histone deacetylase 6 (HDAC6) selective inhibitors: a patent evaluation (WO2014181137).Expert Opin Ther Pat. 2017 Mar;27(3):229-236.
• [14] Cyclin-dependent kinase inhibitors for cancer therapy: a patent review (2009 - 2014).Expert Opin Ther Pat. 2015;25(9):953-70.
• [15] HDAC inhibitors: a 2013-2017 patent survey.Expert Opin Ther Pat. 2018 Apr 19:1-17.
• [16] Heterocyclic ketones as inhibitors of histone deacetylase. Bioorg Med Chem Lett. 2003 Nov 17;13(22):3909-13.
• [17] Trifluoromethyl ketones as inhibitors of histone deacetylase. Bioorg Med Chem Lett. 2002 Dec 2;12(23):3443-7.
• [18] New sulfurated derivatives of valproic acid with enhanced histone deacetylase inhibitory activity. Bioorg Med Chem Lett. 2008 Mar 15;18(6):1893-7.
• [19] Design and synthesis of a novel class of histone deacetylase inhibitors. Bioorg Med Chem Lett. 2001 Nov 5;11(21):2847-50.
• [20] Structure-based optimization of phenylbutyrate-derived histone deacetylase inhibitors. J Med Chem. 2005 Aug 25;48(17):5530-5.
• [21] Zn2+-chelating motif-tethered short-chain fatty acids as a novel class of histone deacetylase inhibitors. J Med Chem. 2004 Jan 15;47(2):467-74.
• [22] Histone deacetylase inhibitors. J Med Chem. 2003 Nov 20;46(24):5097-116.
• [23] Novel inhibitors of human histone deacetylases: design, synthesis, enzyme inhibition, and cancer cell growth inhibition of SAHA-based non-hydroxama... J Med Chem. 2005 Feb 24;48(4):1019-32.
• [24] Inhibitors of human histone deacetylase: synthesis and enzyme and cellular activity of straight chain hydroxamates. J Med Chem. 2002 Feb 14;45(4):753-7.
• [25] Chemical phylogenetics of histone deacetylases. Nat Chem Biol. 2010 Mar;6(3):238-243.
• [26] Design of novel histone deacetylase inhibitors. Bioorg Med Chem Lett. 2007 Aug 15;17(16):4619-24.
• [27] Stereodefined and polyunsaturated inhibitors of histone deacetylase based on (2E,4E)-5-arylpenta-2,4-dienoic acid hydroxyamides. Bioorg Med Chem Lett. 2004 May 17;14(10):2477-81.
• [28] Acylurea connected straight chain hydroxamates as novel histone deacetylase inhibitors: Synthesis, SAR, and in vivo antitumor activity. Bioorg Med Chem Lett. 2010 Jun 1;20(11):3314-21.
• [29] Inhibitors selective for HDAC6 in enzymes and cells. Bioorg Med Chem Lett. 2010 Dec 1;20(23):7067-70.
• [30] Aromatic sulfide inhibitors of histone deacetylase based on arylsulfinyl-2,4-hexadienoic acid hydroxyamides. J Med Chem. 2006 Jan 26;49(2):800-5.
• [31] Structure-activity relationships of aryloxyalkanoic acid hydroxyamides as potent inhibitors of histone deacetylase. Bioorg Med Chem Lett. 2007 Jan 1;17(1):136-41.
• [32] Alpha-keto amides as inhibitors of histone deacetylase. Bioorg Med Chem Lett. 2003 Oct 6;13(19):3331-5.
• [33] A novel series of histone deacetylase inhibitors incorporating hetero aromatic ring systems as connection units. Bioorg Med Chem Lett. 2003 Nov 3;13(21):3817-20.
• [34] Design, synthesis, structure--selectivity relationship, and effect on human cancer cells of a novel series of histone deacetylase 6-selective inhib... J Med Chem. 2007 Nov 1;50(22):5425-38.
• [35] 3D-QSAR studies of HDACs inhibitors using pharmacophore-based alignment. Eur J Med Chem. 2009 Jul;44(7):2868-76.
• [36] Identification and optimisation of a series of substituted 5-pyridin-2-yl-thiophene-2-hydroxamic acids as potent histone deacetylase (HDAC) inhibit... Bioorg Med Chem Lett. 2007 Jan 15;17(2):363-9.
• [37] Non-peptide macrocyclic histone deacetylase inhibitors. J Med Chem. 2009 Jan 22;52(2):456-68.
• [38] Evaluation of antiangiogenic activity of azumamides by the in vitro vascular organization model using mouse induced pluripotent stem (iPS) cells. Bioorg Med Chem Lett. 2008 May 1;18(9):2982-4.
• [39] Molecular design of histone deacetylase inhibitors by aromatic ring shifting in chlamydocin framework. Bioorg Med Chem. 2007 Dec 15;15(24):7830-9.
• [40] Three new cyclostellettamines, which inhibit histone deacetylase, from a marine sponge of the genus Xestospongia. Bioorg Med Chem Lett. 2004 May 17;14(10):2617-20.
• [41] Gymnochromes E and F, cytotoxic phenanthroperylenequinones from a deep-water crinoid, Holopus rangii. J Nat Prod. 2010 Apr 23;73(4):712-5.
• [42] Synthesis and biological characterization of the histone deacetylase inhibitor largazole and C7- modified analogues. J Med Chem. 2010 Jun 24;53(12):4654-67.
• [43] Biological and biophysical properties of the histone deacetylase inhibitor suberoylanilide hydroxamic acid are affected by the presence of short al... J Med Chem. 2010 Mar 11;53(5):1937-50.
• [44] Bioorg Med Chem Lett. 2008 Dec 1;18(23):6104-9. Epub 2008 Oct 14.SAR profiles of spirocyclic nicotinamide derived selective HDAC1/HDAC2 inhibitors (SHI-1:2).
• [45] N-(2-Amino-phenyl)-4-(heteroarylmethyl)-benzamides as new histone deacetylase inhibitors. Bioorg Med Chem Lett. 2007 Dec 15;17(24):6729-33.
• [46] Novel aminophenyl benzamide-type histone deacetylase inhibitors with enhanced potency and selectivity. J Med Chem. 2007 Nov 15;50(23):5543-6.
• [47] Mercaptoamide-based non-hydroxamic acid type histone deacetylase inhibitors. Bioorg Med Chem Lett. 2005 Apr 15;15(8):1969-72.
• [48] Design, synthesis and preliminary biological evaluation of N-hydroxy-4-(3-phenylpropanamido)benzamide (HPPB) derivatives as novel histone deacetyla... Eur J Med Chem. 2009 Nov;44(11):4470-6.
• [49] Histone deacetylase inhibitors: from bench to clinic. J Med Chem. 2008 Mar 27;51(6):1505-29.
• [50] Sulfamides as novel histone deacetylase inhibitors. Bioorg Med Chem Lett. 2009 Jan 15;19(2):336-40.
• [51] Isoxazole moiety in the linker region of HDAC inhibitors adjacent to the Zn-chelating group: effects on HDAC biology and antiproliferative activity. Bioorg Med Chem Lett. 2009 Jun 1;19(11):3023-6.
• [52] Selective histone deacetylase 6 inhibitors bearing substituted urea linkers inhibit melanoma cell growth. J Med Chem. 2012 Nov 26;55(22):9891-9.
• [53] Histone deacetylase inhibitors through click chemistry. J Med Chem. 2008 Dec 11;51(23):7417-27.
• [54] Structure-activity relationships on phenylalanine-containing inhibitors of histone deacetylase: in vitro enzyme inhibition, induction of differenti... J Med Chem. 2002 Jul 18;45(15):3296-309.
• [55] On the function of the 14 A long internal cavity of histone deacetylase-like protein: implications for the design of histone deacetylase inhibitors. J Med Chem. 2004 Jun 17;47(13):3409-17.
• [56] N-Hydroxy-(4-oxime)-cinnamide: a versatile scaffold for the synthesis of novel histone deacetylase [correction of deacetilase] (HDAC) inhibitors. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2346-9.